Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Change in Accured Expenses (2020 - 2025)

Historic Change in Accured Expenses for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $2.1 million.

  • Treace Medical Concepts' Change in Accured Expenses rose 13110.13% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 15071.84%. This contributed to the annual value of -$7.9 million for FY2024, which is 20498.14% down from last year.
  • According to the latest figures from Q3 2025, Treace Medical Concepts' Change in Accured Expenses is $2.1 million, which was up 13110.13% from $857000.0 recorded in Q2 2025.
  • Over the past 5 years, Treace Medical Concepts' Change in Accured Expenses peaked at $9.5 million during Q4 2023, and registered a low of -$6.9 million during Q1 2024.
  • In the last 5 years, Treace Medical Concepts' Change in Accured Expenses had a median value of $939000.0 in 2023 and averaged $535210.5.
  • In the last 5 years, Treace Medical Concepts' Change in Accured Expenses surged by 78377.43% in 2022 and then crashed by 67565.51% in 2024.
  • Quarter analysis of 5 years shows Treace Medical Concepts' Change in Accured Expenses stood at $5.9 million in 2021, then tumbled by 31.67% to $4.0 million in 2022, then surged by 136.28% to $9.5 million in 2023, then tumbled by 48.85% to $4.8 million in 2024, then tumbled by 56.33% to $2.1 million in 2025.
  • Its Change in Accured Expenses was $2.1 million in Q3 2025, compared to $857000.0 in Q2 2025 and -$6.2 million in Q1 2025.